Detection of respiratory viruses in adults with suspected COVID-19 in Kuala Lumpur, Malaysia
- PMID: 34739838
- PMCID: PMC8526124
- DOI: 10.1016/j.jcv.2021.105000
Detection of respiratory viruses in adults with suspected COVID-19 in Kuala Lumpur, Malaysia
Abstract
Background: Reports of co-circulation of respiratory viruses during the COVID-19 pandemic and co-infections with SARS-CoV-2 vary. However, limited information is available from developing countries.
Objectives: We aimed to investigate the incidence of respiratory viruses in adult patients with suspected COVID-19 in Kuala Lumpur, Malaysia.
Study design: We collected 198 respiratory samples from adult patients hospitalized with suspected COVID-19 in a single teaching hospital in Kuala Lumpur in February-May 2020 and tested combined oro-nasopharyngeal swabs with the NxTAG Respiratory Pathogen Panel (Luminex) and Allplex RV Essential (Seegene) assays. Forty-five negative samples further underwent viral metagenomics analysis.
Results: Of the 198 samples, 74 (37.4%) had respiratory pathogens, including 56 (28.3%) with SARS-CoV-2 and 18 (9.1%) positive for other respiratory pathogens. There were five (2.5%) SARS-CoV-2 co-infections, all with rhinovirus/enterovirus. Three samples (6.7%; 3/45) had viruses identified by metagenomics, including one case of enterovirus D68 and one of Saffold virus genotype 6 in a patient requiring ICU care. Most of the COVID-19 patients (91.1%; 51/56) had mild symptoms but 5.4% (3/56) died.
Conclusion: During the early COVID-19 period, common respiratory viruses other than SARS-CoV-2 only accounted for 9.1% of hospitalization cases with ARI and co-infections with SARS-CoV-2 were rare. Continued surveillance is important to understand the impact of COVID-19 and its associated public health control measures on circulation of other respiratory viruses. Metagenomics can identify unexpected or rare pathogens, such as Saffold virus, which is rarely described in adults.
Keywords: COVID-19; Malaysia; SARS-CoV-2; Saffold virus; respiratory viruses; viral metagenomics.
Copyright © 2021. Published by Elsevier B.V.
Conflict of interest statement
The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Figures


References
-
- Press statement from the Director-General of Health, 21 September 2021: Updates on the coronavirus disease 2019 (COVID-19) situation in Malaysia. https://kpkesihatan.com/2021/09/21/kenyataan-akhbar-kpk-21-september-202..., 2021 (accessed 21 September 2021).
-
- Burrel S., Hausfater P., Dres M., Pourcher V., Luyt C.-E., Teyssou E., Soulié C., Calvez V., Marcelin A.-G., Boutolleau D. Co-infection of SARS-CoV-2 with other respiratory viruses and performance of lower respiratory tract samples for the diagnosis of COVID-19. International Journal of Infectious Diseases. 2021;102:10–13. doi: 10.1016/j.ijid.2020.10.040. - DOI - PMC - PubMed
-
- Xu L., Zhu Y., Ren L., Xu B., Liu C., Xie Z., Shen K. Characterization of the nasopharyngeal viral microbiome from children with community-acquired pneumonia but negative for Luminex xTAG respiratory viral panel assay detection. Journal of Medical Virology. 2017;89:2098–2107. doi: 10.1002/jmv.24895. - DOI - PMC - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous